PROJECT SUMMARY / ABSTRACT
Senescence is a state of permanent cell cycle arrest, and can occur during development (programmed
senescence), or be triggered by a variety of stressors, like telomere shortening (defined as replicative
senescence), oxidative stress DNA damage, and oncogene activation (stress-induced premature senescence).
Senescent cells remain metabolically active and secrete high concentrations of signaling molecules into the
tissue microenvironment (known as Senescence-Associated Secretory Phenotype, or SASP). These secreted
factors can activate immune systems to initiate clearance of senescent cells, which contribute to tumor
suppression, would healing and tissue homeostasis. When the immunosurveillance fails to eliminate senescent
cells, their accumulation causes inflammation and contributes to a variety of diseases, including cancer,
metabolic disorders, fibrosis, diabetes, brain disorders, osteoarthritis, and kidney disease.
These complex and important roles in ageing and diseases prompt extensive interest in developing
imaging methods to detect senescence cells. A number of optical imaging probes have been developed by
targeting senescence-associated beta-galactosidase (SA-b-gal) activity. However, their use in vivo is limited
due to poor penetration and scattering photons in living tissues. Several SPECT, MRI, and PET probes have
been reported to address this limitation, but they displayed either poor cell permeability and/or sensitivity. In
the case of PET tracers, they generally suffer from a lack of efficient signal retention mechanism.
This research proposes to develop a novel PET tracer for in vivo imaging of senescence in a mouse
model of cancer by targeting a novel lysosomal enzyme and using an in celluo probe assembly retention
strategy. There are two Specific Aims: 1) synthesize the PET tracer and assess its capacity to detecting
senescence in cell culture; 2) validate the PET tracer in animal models of therapy induced senescence. This
project would provide a more specific and sensitive PET tracer for imaging cell senescence in vivo and for
future translation into human studies.
Public Health Relevance Statement
Project Relevance
The proposed research aims to develop a novel PET tracer to image senescence cells in vivo. The
ability of non-invasive imaging of senescence will help for both fundamental senescence research and
development of senescence targeting therapeutics in treating cancer and ageing.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
009214214
UEI
HJD6G4D6TJY5
Project Start Date
10-July-2023
Project End Date
30-June-2025
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$194,579
Direct Costs
$125,000
Indirect Costs
$69,579
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$194,579
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21EB034967-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21EB034967-02
Patents
No Patents information available for 5R21EB034967-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21EB034967-02
Clinical Studies
No Clinical Studies information available for 5R21EB034967-02
News and More
Related News Releases
No news release information available for 5R21EB034967-02
History
No Historical information available for 5R21EB034967-02
Similar Projects
No Similar Projects information available for 5R21EB034967-02